Avanos Medical (AVNS) 44th Annual J.P. Morgan Healthcare Conference summary

Strategic overview and leadership

• CEO with 30+ years of healthcare leadership is driving strategic imperatives and transformation initiatives.

• Focused on durable long-term growth and value creation through a sharpened strategy and operational discipline.

• New management team in place, emphasizing execution and performance elevation.

• Two main business segments: specialty nutrition systems and pain management and recovery, generating ~$700M in revenue.

• Strong global direct sales organization and market-leading positions in core categories, with expanded presence in North America, EMEA, APAC, and LATAM.

Executive leadership and vision

• Vision targets $1B in revenue by 2030, focusing on growth, M&A, operational efficiency, and tariff mitigation.

• Priority initiatives include accelerating growth in core segments, optimizing portfolio, and expanding global sales.

Specialty nutrition systems (SNS)

• Market leader in guided feeding tube placement (CORTRAK), low-profile G-tubes (MIC-KEY), and U.S. enteral feeding solutions (NeoMed ENFit).

• SNS leads with #1 US market positions in short-term, long-term, and neonatal feeding portfolios.

• Double-digit growth in short-term feeding and neonatal solutions, supported by innovation and acquisitions like Nexus TKO.

• MIC-KEY Cares app launched, engaging 5,000 participants in five months.

• U.S. neonatal feeding business outperforms the market, driven by low birth weights and ENFit adoption.